FDA Drug Recalls

Recalls / Class III

Class IIID-0424-2017

Product

Cytotec (misoprostol) Tablets, 200 mcg, 100 Tablets blister pack (10X10), For in-institution use only, Rx only, Distributed by G.D. Searle, Division of Pfizer, Inc., NY, NY --- NDC 0025-1461-34

Brand name
Cytotec
Generic name
Misoprostol
Active ingredient
Misoprostol
Route
Oral
NDCs
0025-1451, 0025-1461
FDA application
NDA019268
Affected lot / code info
1) Lot # B08493 - Expiration Date 12/2016; 2) Lot # B13230 - Expiration Date 08/2018

Why it was recalled

Failed Impurities/Degradations Specifications; Out of specification results for two known degradation products and total impurities at 18 months

Recalling firm

Firm
Pfizer Inc.
Manufacturer
Pfizer Laboratories Div Pfizer Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
235 East 42nd Street, New York, New York 10017-5703

Distribution

Quantity
1,706 cartons
Distribution pattern
Nationwide

Timeline

Recall initiated
2016-09-09
FDA classified
2017-01-06
Posted by FDA
2017-01-18
Terminated
2017-08-18
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0424-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Cytotec · FDA Drug Recalls